Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study

NCT07296549 · tracked via the Priya Life Science Egypt tracker

Sponsor

Venus Research Center

Phase

Observational

Started

2026-06-01

Last updated

2025-12-29

Condition(s) studied

MelasmaMelasma (Facial Melasma)

Study summary

This study aims to gather expert opinions on the best ways to treat and manage melasma, a common skin condition characterized by dark patches on the face. Using a method called the Delphi Method, a group of dermatologists and other specialists will participate in several rounds of surveys to share their insights and reach a consensus on the most effective treatments and management strategies. The goal is to create a set of evidence-based guidelines that can help doctors provide more consistent, effective care for patients with melasma. The study will ensure that all experts' opinions are anonymous, and the results will be shared to improve treatment practices worldwide.

Eligibility

Sex

ALL

Min age

25 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Board-certified or equivalent dermatologist, * Minimum of 5 years of post-certification clinical experience in the management of MELASMA, * Willingness to participate in all Delphi rounds. Exclusion Criteria: * Inability or unwillingness to complete Delphi rounds. * Lack of clinical experience with MELASMA * Industry representatives without direct clinical practice

Primary outcome measure(s)

Consensus on Diagnostic & therapeutic Criteria for Melasma — 6-12 weeks
Establishment of expert consensus on core domains of melasma diagnosis and management measured by the proportion of statements reaching predefined consensus agreement after completion of delphi rounds

Trial sites (1)

Facility	City	Region	Status
Venus Research Center	Cairo	Egypt

More Venus Research Center trials in Egypt

Expert Consensus on the Clinical Use of Skin Boosters: A Delphi-Based Recommendation Framework Enrolling by invitation

Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study Enrolling by invitation

Consensus Guidelines for Pre- and Post-Procedure Skincare in Aesthetic Treatments Enrolling by invitation

Consensus on Skin Care in Breast Cancer Patients Enrolling by invitation

Expert Consensus on the Use of Nutraceuticals in Pregnancy: A Delphi Study Enrolling by invitation

Other trials for the same condition

Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma Recruiting

Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study Starting soon

Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07296549 on ClinicalTrials.gov ↗ ← All trials in Egypt